feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Tingling Arm: A Deadly Glioblastoma Warning

Tingling Arm: A Deadly Glioblastoma Warning

8 Jan

•

Summary

  • A tingling arm symptom preceded a glioblastoma diagnosis in a 38-year-old man.
  • He faces a prognosis of 12 to 18 months with an aggressive brain tumor.
  • Limited treatment access in the UK prompts patients to seek costly overseas options.
Tingling Arm: A Deadly Glioblastoma Warning

A man's life was irrevocably altered when a tingling sensation in his arm signaled an aggressive brain tumor. Matt Collins, 38, experienced a sudden loss of function in his left arm, leading to his diagnosis of glioblastoma, the most aggressive form of brain cancer. Doctors delivered a grim prognosis of 12 to 18 months, a reality that profoundly impacted Collins and his family.

Following successful surgery in 2023 to remove the golf ball-sized tumor, it recurred, and subsequent chemotherapy proved ineffective. This setback underscores the severe limitations in treatment options for brain tumors in the UK, which are the leading cause of cancer death in children and individuals under 40. Many patients, like Collins, must increasingly seek expensive treatments abroad.

trending

RBI objections: Manappuram shares fall

trending

Delhi NCR cold wave

trending

Gurgaon fog disrupts travel

trending

GIFT Nifty down 40 points

trending

BHEL stock jumps after order

trending

APTEL hearing affects IEX share

trending

Chennai weekend heavy rain forecast

trending

Nifty Q3 earnings season

trending

Hang Seng Bank privatisation

Collins's case highlights the disparity in research funding and treatment accessibility. He received a bespoke vaccine, DcVax-L, thanks to public donations, costing £100,000. He now eyes a German therapy at £16,000 per cycle, questioning why such treatments aren't more accessible through the NHS, a sentiment echoed by research charities advocating for increased investment and better patient sample handling.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Matt Collins experienced a tingling sensation in his arm, which later led to a sudden loss of function.
Glioblastoma is the most aggressive type of brain tumor, with Matt Collins given a prognosis of 12 to 18 months.
Access to cutting-edge immunotherapies and specialist drug trials is scarce in the UK, forcing patients to fund private or overseas care.

Read more news on

Healthside-arrow

You may also like

Mom Battles Aggressive Brain Cancer After Losing 3 Kids

6 Jan • 10 reads

Michael Bolton: Daughters Remind Him 'What's Worth Fighting For'

23 Dec, 2025 • 12 reads

article image

Man's Tinnitus Battle Reveals Brain Tumor

18 Dec, 2025 • 114 reads

article image

Father's Seizure Reveals Aggressive Brain Cancer

13 Dec, 2025 • 136 reads

article image

Mum with 12-month prognosis seeks German treatment

6 Dec, 2025 • 188 reads

article image